Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation

J Hematol Oncol. 2013 Dec 17;6:94. doi: 10.1186/1756-8722-6-94.

Abstract

Viral infections are important causes of morbidity and mortality after allogeneic stem cell hematopoietic transplantation (allo-HSCT). Although most viral infections present with asymptomatic or subclinical manifestations, viruses may result in fatal complications in severe immunocompromised recipients. Reactivation of latent viruses, such as herpesviruses, is frequent during the immunosuppression that occurs with allo-HSCT. Viruses acquired from community, such as the respiratory and gastrointestinal viruses, are also important pathogens of post-transplant viral diseases. Currently, molecular diagnostic methods have replaced or supplemented traditional methods, such as viral culture and antigen detection, in diagnosis of viral infections. The utilization of polymerase chain reaction facilitates the early diagnosis. In view of lacking efficacious agents for treatment of viral diseases, prevention of viral infections is extremely valuable. Application of prophylactic strategies including preemptive therapy reduces viral infections and diseases. Adoptive cellular therapy for restoring virus-specific immunity is a promising method in the treatment of viral diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Immunocompromised Host
  • Transplantation Conditioning / adverse effects
  • Transplantation Conditioning / methods
  • Virus Diseases / diagnosis
  • Virus Diseases / drug therapy
  • Virus Diseases / etiology*
  • Virus Diseases / prevention & control